Page last updated: 2024-09-05

zeneca zd 6169 and Disease Models, Animal

zeneca zd 6169 has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brioni, JD; Brune, ME; Coghlan, MJ; Fabiyi, AC; Gopalakrishnan, M; Lynch, JJ	1
Calzadilla, SV; Cox, BF; Fryer, RM; Gopalakrishnan, M; Hu, Y; Lin, CT; Marsh, KC; Preusser, LC; Reinhart, GA; Xu, H	1

Other Studies

2 other study(ies) available for zeneca zd 6169 and Disease Models, Animal

Article	Year
In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats. BJU international, 2003, Volume: 91, Issue:3 Topics: Amides; Animals; Benzophenones; Calcium Channels; Cromakalim; Cyclobutanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Male; Muscarinic Antagonists; Muscle Contraction; Nitriles; Rats; Rats, Sprague-Dawley; Reflex, Abnormal; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Neurogenic; Vasodilator Agents	2003
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine. Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2 Topics: Adenosine Triphosphate; Amides; Animals; Benzophenones; Blood Pressure; Cyclic S-Oxides; Cyclobutanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Heart Rate; Hypotension; Infusions, Intravenous; Ion Channel Gating; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Nitriles; Pharmaceutical Vehicles; Polyethylene Glycols; Potassium Channels; Quinolones; Tachycardia; Urinary Bladder; Urinary Incontinence; Vascular Resistance	2004

Article

Year

In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats.

BJU international, 2003, Volume: 91, Issue:3

Topics: Amides; Animals; Benzophenones; Calcium Channels; Cromakalim; Cyclobutanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Male; Muscarinic Antagonists; Muscle Contraction; Nitriles; Rats; Rats, Sprague-Dawley; Reflex, Abnormal; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Neurogenic; Vasodilator Agents

2003

(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.

Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2

Topics: Adenosine Triphosphate; Amides; Animals; Benzophenones; Blood Pressure; Cyclic S-Oxides; Cyclobutanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Heart Rate; Hypotension; Infusions, Intravenous; Ion Channel Gating; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Nitriles; Pharmaceutical Vehicles; Polyethylene Glycols; Potassium Channels; Quinolones; Tachycardia; Urinary Bladder; Urinary Incontinence; Vascular Resistance

2004